Intragastric injection of botulinum toxin A for the treatment of obesity

Intragastric injection of botulinum toxin A for the treatment of obesity - Intragastric injection of botulinum toxin A for the treatment of obesity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020931

Enrollment

Registered

2016-03-01

Start date

2016-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Injections were performed via 25G EUS needle under real-time EUS guidance,targeting the gastric muscularis propria by 20 U in ten places

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with more than BMI30

Exclusion criteria

Exclusion criteria: 1, myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis 2, Patient with the high breathing disorder 3, Pregnant woman, woman with the possibility of the pregnancy,nursing girl

Design outcomes

Primary

Measure	Time frame
Weight loss after 24 weeks	—

Secondary

Measure	Time frame
Incidence of complications	—

Countries

Japan

Contacts

Public ContactRyo Kanazawa

Juntendo University Hospital Department of Gastroenterology

rkanaza@juntendo.ac.jp03-3813-3111(70226)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026